#USA #Select Medical #Shareholder Rights #Kaskela Law #Newtown Square

Investigation into Select Medical Holdings Buyout Price

The proposed buyout of Select Medical Holdings Corp. (NYSE: SEM), priced at $16.50 per share, has raised questions among investors about its fairness. Kaskela Law, a reputable firm specializing in investor rights and securities law, is actively investigating whether this buyout price adequately compensates shareholders.

On March 2, 2026, Select Medical confirmed its acquisition by an investment group, marking the end of its public trading status. As shareholders prepare for a transition to cash from their investments, Kaskela Law emphasizes the need for an evaluation of whether these shareholders are receiving just value for their equity. The law firm is scrutinizing the buyout to ensure it aligns with fair market value and the company's future potential.

Concerns Over Fairness

One point of contention is that, at the time of the announcement, analysts had set price targets for Select Medical shares as high as $19.00 per share. This discrepancy raises significant concerns about whether the agreed-upon price constitutes a fair offer, especially given that shareholders are losing the ability to trade their shares.

Kaskela Law is particularly focused on determining if the company’s executives or directors acted in the best interest of shareholders or if they may have breached their fiduciary responsibilities in negotiating the buyout terms. Investors are advised to evaluate their positions and understand their rights regarding potential compensations.

Contacting Kaskela Law

Shareholders of Select Medical are encouraged to reach out to Kaskela Law at (484) 229-0750 for further information. The firm offers free consultations to discuss individual cases, potential investor actions, and the steps needed to explore any legal options for seeking additional compensation. Interested parties can also submit their contact information via Kaskela Law's website, ensuring they stay informed about the investigation and their rights.

About Kaskela Law

Founded in 2020, Kaskela Law has specialized in representing investors in cases of securities fraud, corporate governance disputes, and merger and acquisition litigation. The firm operates on a contingency basis, meaning clients do not incur upfront costs for legal representation. Over the years, Kaskela Law has successfully recovered more than $500 million for investors through various settlements and litigations.

For more detailed information about Kaskela Law and their current cases, including recent victories, investors can visit their official website at www.kaskelalaw.com.

Conclusion

As the investigation unfolds, Select Medical's shareholders must remain vigilant regarding their rights and the integrity of the buyout process. Proper legal guidance and timely action could ensure that they receive fair compensation for their investments.